330 related articles for article (PubMed ID: 25704033)
1. Muscle pathology grade for facioscapulohumeral muscular dystrophy biopsies.
Statland JM; Shah B; Henderson D; Van Der Maarel S; Tapscott SJ; Tawil R
Muscle Nerve; 2015 Oct; 52(4):521-6. PubMed ID: 25704033
[TBL] [Abstract][Full Text] [Related]
2. Skeletal muscle regeneration in facioscapulohumeral muscular dystrophy is correlated with pathological severity.
Banerji CRS; Henderson D; Tawil RN; Zammit PS
Hum Mol Genet; 2020 Sep; 29(16):2746-2760. PubMed ID: 32744322
[TBL] [Abstract][Full Text] [Related]
3. Reduced specific force in patients with mild and severe facioscapulohumeral muscular dystrophy.
Lassche S; Voermans NC; Schreuder T; Heerschap A; Küsters B; Ottenheijm CA; Hopman MT; van Engelen BG
Muscle Nerve; 2021 Jan; 63(1):60-67. PubMed ID: 32959362
[TBL] [Abstract][Full Text] [Related]
4. MRI-informed muscle biopsies correlate MRI with pathology and DUX4 target gene expression in FSHD.
Wang LH; Friedman SD; Shaw D; Snider L; Wong CJ; Budech CB; Poliachik SL; Gove NE; Lewis LM; Campbell AE; Lemmers RJFL; Maarel SM; Tapscott SJ; Tawil RN
Hum Mol Genet; 2019 Feb; 28(3):476-486. PubMed ID: 30312408
[TBL] [Abstract][Full Text] [Related]
5. Functional muscle impairment in facioscapulohumeral muscular dystrophy is correlated with oxidative stress and mitochondrial dysfunction.
Turki A; Hayot M; Carnac G; Pillard F; Passerieux E; Bommart S; Raynaud de Mauverger E; Hugon G; Pincemail J; Pietri S; Lambert K; Belayew A; Vassetzky Y; Juntas Morales R; Mercier J; Laoudj-Chenivesse D
Free Radic Biol Med; 2012 Sep; 53(5):1068-79. PubMed ID: 22796148
[TBL] [Abstract][Full Text] [Related]
6. Facioscapulohumeral dystrophy transcriptome signatures correlate with different stages of disease and are marked by different MRI biomarkers.
van den Heuvel A; Lassche S; Mul K; Greco A; San León Granado D; Heerschap A; Küsters B; Tapscott SJ; Voermans NC; van Engelen BGM; van der Maarel SM
Sci Rep; 2022 Jan; 12(1):1426. PubMed ID: 35082321
[TBL] [Abstract][Full Text] [Related]
7. Milder phenotype in facioscapulohumeral dystrophy with 7-10 residual D4Z4 repeats.
Statland JM; Donlin-Smith CM; Tapscott SJ; Lemmers RJ; van der Maarel SM; Tawil R
Neurology; 2015 Dec; 85(24):2147-50. PubMed ID: 26561289
[TBL] [Abstract][Full Text] [Related]
8. Muscle MRI findings in facioscapulohumeral muscular dystrophy.
Gerevini S; Scarlato M; Maggi L; Cava M; Caliendo G; Pasanisi B; Falini A; Previtali SC; Morandi L
Eur Radiol; 2016 Mar; 26(3):693-705. PubMed ID: 26115655
[TBL] [Abstract][Full Text] [Related]
9. Correlation Between Quantitative MRI and Muscle Histopathology in Muscle Biopsies from Healthy Controls and Patients with IBM, FSHD and OPMD.
Lassche S; Küsters B; Heerschap A; Schyns MVP; Ottenheijm CAC; Voermans NC; van Engelen BGM
J Neuromuscul Dis; 2020; 7(4):495-504. PubMed ID: 32925090
[TBL] [Abstract][Full Text] [Related]
10. MRI as outcome measure in facioscapulohumeral muscular dystrophy: 1-year follow-up of 45 patients.
Andersen G; Dahlqvist JR; Vissing CR; Heje K; Thomsen C; Vissing J
J Neurol; 2017 Mar; 264(3):438-447. PubMed ID: 28000006
[TBL] [Abstract][Full Text] [Related]
11. Muscle pathology from stochastic low level DUX4 expression in an FSHD mouse model.
Bosnakovski D; Chan SSK; Recht OO; Hartweck LM; Gustafson CJ; Athman LL; Lowe DA; Kyba M
Nat Commun; 2017 Sep; 8(1):550. PubMed ID: 28916757
[TBL] [Abstract][Full Text] [Related]
12. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy.
Osborne RJ; Welle S; Venance SL; Thornton CA; Tawil R
Neurology; 2007 Feb; 68(8):569-77. PubMed ID: 17151338
[TBL] [Abstract][Full Text] [Related]
13. A cross sectional study of two independent cohorts identifies serum biomarkers for facioscapulohumeral muscular dystrophy (FSHD).
Petek LM; Rickard AM; Budech C; Poliachik SL; Shaw D; Ferguson MR; Tawil R; Friedman SD; Miller DG
Neuromuscul Disord; 2016 Jul; 26(7):405-13. PubMed ID: 27185459
[TBL] [Abstract][Full Text] [Related]
14. DUX4 Signalling in the Pathogenesis of Facioscapulohumeral Muscular Dystrophy.
Lim KRQ; Nguyen Q; Yokota T
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979100
[TBL] [Abstract][Full Text] [Related]
15. [Facioscapulohumeral muscular dystrophy. The spectrum of clinical manifestations and molecular genetic changes].
Krasnianski M; Neudecker S; Eger K; Schulte-Mattler W; Zierz S
Nervenarzt; 2003 Feb; 74(2):151-8. PubMed ID: 12596016
[TBL] [Abstract][Full Text] [Related]
16. Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy.
Kan HE; Scheenen TW; Wohlgemuth M; Klomp DW; van Loosbroek-Wagenmans I; Padberg GW; Heerschap A
Neuromuscul Disord; 2009 May; 19(5):357-62. PubMed ID: 19329315
[TBL] [Abstract][Full Text] [Related]
17. miRNA expression in control and FSHD fetal human muscle biopsies.
Portilho DM; Alves MR; Kratassiouk G; Roche S; Magdinier F; de Santana EC; Polesskaya A; Harel-Bellan A; Mouly V; Savino W; Butler-Browne G; Dumonceaux J
PLoS One; 2015; 10(2):e0116853. PubMed ID: 25692472
[TBL] [Abstract][Full Text] [Related]
18. An instrumented timed up and go in facioscapulohumeral muscular dystrophy.
Huisinga J; Bruetsch A; Mccalley A; Currence M; Herbelin L; Jawdat O; Pasnoor M; Dimachkie M; Barohn R; Statland J
Muscle Nerve; 2018 Mar; 57(3):503-506. PubMed ID: 28877559
[TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of mesoangioblasts from facioscapulohumeral muscular dystrophy muscle biopsies.
Morosetti R; Mirabella M; Gliubizzi C; Broccolini A; Sancricca C; Pescatori M; Gidaro T; Tasca G; Frusciante R; Tonali PA; Cossu G; Ricci E
Stem Cells; 2007 Dec; 25(12):3173-82. PubMed ID: 17761758
[TBL] [Abstract][Full Text] [Related]
20. Quantitative muscle ultrasound versus quantitative magnetic resonance imaging in facioscapulohumeral dystrophy.
Janssen BH; Pillen S; Voet NB; Heerschap A; van Engelen BG; van Alfen N
Muscle Nerve; 2014 Dec; 50(6):968-75. PubMed ID: 24659533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
